Search for: "State v. Merz"
Results 1 - 15
of 15
Sorted by Relevance
|
Sort by Date
2 Apr 2009, 9:54 am
The IPKat has been passed an early copy of Mr Justice Floyd's judgment from earlier today in the case of Synthon v Merz, which relates to the esoteric outer reaches of how European Community law on Supplementary Protection Certificates (SPCs) should be interpreted. [read post]
30 Apr 2012, 7:00 am
At the close of the nine day bench trial, Judge Guilford stated that he had concluded there were "dramatic acts of misappropriation" and his opinion emphasized that his findings of fact were "largely based" on the credibility of the witnesses. [read post]
12 Mar 2012, 9:20 am
Merz Findings of Fact and Conclusions of Law.pdf (178.19 kb) Allergan v. [read post]
13 Dec 2007, 12:22 am
State Farm Mut. [read post]
14 Nov 2017, 8:53 am
In Merz v. [read post]
23 Jul 2009, 8:27 pm
On March 14, Merz engaged in a proffer session with the Government [which] took place pursuant to a proffer letter, executed by Assistant United States Attorney Denise Wolf, Merz, and Merz's then-counsel, David Kozlow. [read post]
26 Jan 2017, 1:51 pm
Supreme Court in Glossip v. [read post]
19 Nov 2013, 3:55 am
Judge Wu's preliminary injunction in Angelotti Chiropractic v. [read post]
21 May 2014, 4:46 am
It stated, insofar as is relevant here,`1. [read post]
25 May 2010, 5:33 pm
” The case cites United States v. [read post]
8 Mar 2012, 8:00 am
In Grace Hunt IT Solutions, LLC v. [read post]
29 Mar 2011, 9:19 pm
Merck (Kluwer Patent Blog) Keppra (Levetiracetam) – US: Orange Book patent listing precipitates DJ action to trigger generic Keppra XR 180-day exclusivity forfeiture: Par Pharmaceutical v UCB et al (FDA Law Blog) (Patent Docs) Naropin (Ropivacaine) – US: Judge O’Malley in dissent: Patent assignments should be a matter of state law: Abraxis BioScience v. [read post]
10 Apr 2017, 6:48 am
Dynasplint Systems, Inc., April 3, 2017, Merz, M.). [read post]
2 Jan 2019, 8:28 pm
Merz, 510 F.3d 157 (2nd Cir. 2007). [read post]
26 Oct 2020, 2:49 am
The summary of product characteristics provides for a mandatory premedication regime under which the drug must be combined with vitamin B 12, as also stated in patent EP 508. [read post]
